SEC Tracker
Get the app

Interpace Biosciences IDXG

Interpace Biosciences reports Q3 2026 results.

Form
8-K
Filed
Importance
Routine
  1. Q3 2026 results announced on Oct 14, 2026.
  2. Forward-looking statements included in the report.

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Interpace Biosciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. Global Innovative Platforms GIPL public float $3M, Sep 30, 2025
  2. ENDRA Life Sciences NDRA public float $3M, Jun 30, 2025
  3. Bluejay Diagnostics BJDX public float $3M, Jun 30, 2025
  4. Stimcell Energetics STME public float $2M, Nov 30, 2025
  5. LogicMark LGMK public float $2M, Jun 30, 2025